Chimeric antigen receptor therapy for B-cell malignancies

Abstract

We presented data showing that the CART-19 cells expressing the 4-1BB signaling do-main can have unprecedented and massive in-vivo expansion, traffic to tumor sites, per-sist long term in vivo, and induce rapid and potent anti-tumor activity in chemotherapy refractory CLL patients. © Ivyspring International Publisher.